THE CIRCADIAN CLOCK GENE PER1 SUPPRESSES CANCER CELL PROLIFERATION AND TUMOR GROWTH AT SPECIFIC TIMES OF DAY

REFERENCES

• Albrecht U, Zheng B, Larkin D, Sun ZS, Lee CC. (2001). MPer1 and mper2 are essential for normal resetting of the circadian clock. J. Biol. Rhythms 16: 100–104.
   PubMed Web of Science ®Google Scholar
• Bae K, Jin X, Maywood ES, Hastings MH, Reppert SM, Weaver DR. (2001). Differential functions of mPer1, mPer2, and mPer3 in the SCN circadian clock. Neuron 30: 525–536.
   PubMed Web of Science ®Google Scholar
• Bjarnason GA, Jordan RC, Wood PA, Li Q, Lincoln DW, Sothern RB, Hrushesky WJ, Ben-David Y. (2001). Circadian expression of clock genes in human oral mucosa and skin: Association with specific cell-cycle phases. Am. J. Pathol. 158: 1793–1801.
   PubMed Web of Science ®Google Scholar
• Dardente H, Cermakian N. (2007). Molecular circadian rhythms in central and peripheral clocks in mammals. Chronobiol. Int. 24: 195–213.
   PubMed Web of Science ®Google Scholar
• Devroe E, Silver PA. (2002). Retrovirus-delivered siRNA. BMC Biotechnol. 2: 15–19.
   PubMedGoogle Scholar
• Fu L, Lee CC. (2003). The circadian clock: Pacemaker and tumour suppressor. Nat. Rev. Cancer. 3: 350–361.
   PubMed Web of Science ®Google Scholar
• Fu L, Pelicano H, Liu J, Huang P, Lee C. (2002). The circadian gene Period2 plays an important role in tumor suppression and DNA damage response in vivo. Cell 111: 41–50.
   PubMed Web of Science ®Google Scholar
• Gery S, Komatsu N, Baldjyan L, Yu A, Koo D, Koeffler HP. (2006). The circadian gene per1 plays an important role in cell growth and DNA damage control in human cancer cells. Mol. Cell. 22: 375–382.
   PubMed Web of Science ®Google Scholar
• Grechez-Cassiau A, Rayet B, Guillaumond F, Teboul M, Delaunay F. (2008). The circadian clock component BMAL1 is a critical regulator of p21WAF1/CIP1 expression and hepatocyte proliferation. J. Biol. Chem. 283: 4535–4542.
   PubMed Web of Science ®Google Scholar
• Hrushesky WJ. (1985). Circadian timing of cancer chemotherapy. Science 228: 73–75.
   PubMed Web of Science ®Google Scholar
• Hrushesky WJ, Lester B, Lannin D. (1999). Circadian coordination of cancer growth and metastatic spread. Int. J. Cancer. 83: 365–373.
   PubMedGoogle Scholar
• Hua H, Wang Y, Wan C, Liu Y, Zhu B, Yang C, Wang X, Wang Z, Cornelissen-Guillaume G, Halberg F. (2006). Circadian gene mPer2 overexpression induces cancer cell apoptosis. Cancer Sci. 97: 589–596.
   PubMed Web of Science ®Google Scholar
• Hua H, Wang Y, Wan C, Liu Y, Zhu B, Wang X, Wang Z, Ding JM. (2007). Inhibition of tumorigenesis by intratumoral delivery of the circadian gene mPer2 in C57BL/6 mice. Cancer Gene Ther. 14: 815–818.
   PubMed Web of Science ®Google Scholar
• James FO, Boivin DB, Charbonneau S, Bélanger V, Cermakian N. (2007). Expression of clock genes in human peripheral blood mononuclear cells throughout the sleep/wake and circadian cycle. Chronobiol. Int. 24: 1099–1034.
   Google Scholar
• Kobayashi M, Wood PA, Hrushesky WJ. (2002). Circadian chemotherapy for gynecological and genitourinary cancers. Chronobiol. Int. 19: 237–251.
   PubMed Web of Science ®Google Scholar
• Lee C, Etchegaray JP, Cagampang FR, Loudon AS, Reppert SM. (2001). Posttranslational mechanisms regulate the mammalian circadian clock. Cell 107: 855–867.
   PubMed Web of Science ®Google Scholar
• Liu S, Cai Y, Sothern RB, Guan Y, Chan P. (2007). Chronobiologic analysis of circadian patterns in transcription of seven key clock genes in six peripheral tissues in mice. Chronobiol. Int. 24: 793–820.
   PubMed Web of Science ®Google Scholar
• Maltsev VA, Lakatta EG. (2007). Normal heart rhythm is initiated and regulated by an intracellular calcium clock within pacemaker cells. Heart Lung Circ. 16: 335–348.
   PubMedGoogle Scholar
• Matsuo T, Yamaguchi S, Mitsui S, Emi A, Shimoda F, Okamura H. (2003). Control mechanism of the circadian clock for timing of cell division in vivo. Science 302: 255–259.
   PubMed Web of Science ®Google Scholar
• Miller BH, McDearmon EL, Panda S, Hayes KR, Zhang J, Andrews JL, Antoch MP, Walker JR, Esser KA, Hogenesch JB, Takahashi JS. (2007). Circadian and CLOCK-controlled regulation of the mouse transcriptome and cell proliferation. Proc. Natl. Acad. Sci. USA 104: 3342–3347.
   PubMed Web of Science ®Google Scholar
• Motzkus D, Loumi S, Cadenas C, Vinson C, Forssmann WG, Maronde E. (2007). Activation of human period-1 by PKA or CLOCK/BMAL1 is conferred by separate signal transduction pathways. Chronobiol Int. 24: 783–792.
   PubMed Web of Science ®Google Scholar
• Portaluppi F, Touitou Y, Smolensky MH. (2008). Ethical and methodological standards for laboratory and medical biological rhythm research. Chronobiol. Int. 25: 999–1016.
   PubMed Web of Science ®Google Scholar
• Reppert SM, Weaver DR. (2002). Coordination of circadian timing in mammals. Nature 418: 935–941.
   PubMed Web of Science ®Google Scholar
• Schrem H, Klempnauer J, Borlak J. (2002). Liver-enriched transcription factors in liver function and development, part I: The hepatocyte nuclear factor network and liver-specific gene expression. Pharmacol. Rev. 54: 129–158.
   PubMed Web of Science ®Google Scholar
• Schrem H, Klempnauer J, Borlak J. (2004). Liver-enriched transcription factors in liver function and development, part II: The C/EBPs and D site-binding protein in cell cycle control, carcinogenesis, circadian gene regulation, liver regeneration, apoptosis, and liver-specific gene regulation. Pharmacol. Rev. 56: 291–330.
   PubMed Web of Science ®Google Scholar
• Sjoblom T, Jones S, Wood LD, Parsons DW, Lin J, Barber TD, Mandelker D, Leary RJ, Ptak J, Silliman N, Szabo S, Buckhaults P, Farrell C, Meeh P, Markowitz SD, Willis J, Dawson D, Willson JK, Gazdar AF, Hartigan J, Wu L, Liu C, Parmigiani G, Park BH, Bachman KE, Papadopoulos N, Vogelstein B, Kinzler KW, Velculescu VE. (2006). The consensus coding sequences of human breast and colorectal cancers. Science 314: 268–274.
   PubMed Web of Science ®Google Scholar
• Smaaland R, Laerum OD, Lote K, Sletvold O, Sothern RB, Bjerknes R. (1991). DNA synthesis in human bone marrow is circadian stage dependent. Blood 77: 2603–2611.
   PubMed Web of Science ®Google Scholar
• Smolensky MH, Peppas NA. (2007). Chronobiology, drug delivery, and chronotherapeutics. Adv. Drug Deliv. Rev. 59: 828–851.
   PubMed Web of Science ®Google Scholar
• Vansteensel MJ, Michel S, Meijer JH. (2008). Organization of cell and tissue circadian pacemakers: A comparison among species. Brain Res. Rev. 58: 18–47.
   PubMedGoogle Scholar
• Wood PA, Hrushesky WJ, Klevecz R. (1998). Distinct circadian time structures characterize myeloid and erythroid progenitor and multipotential cell clonogenicity as well as marrow precursor proliferation dynamics. Exp. Hematol. 26: 523–533.
   PubMedGoogle Scholar
• Wood PA, Du-Quiton J, You S, Hrushesky WJ. (2006). Circadian clock coordinates cancer cell cycle progression, thymidylate synthase, and 5-fluorouracil therapeutic index. Mol. Cancer Ther. 5: 2023–2033.
   PubMed Web of Science ®Google Scholar
• Wood PA, Yang X, Taber A, Oh EY, Ansell C, Ayers SE, Al-Assaad Z, Carnevale K, Berger FG, Pena MM, Hrushesky WJ. (2008). Period 2 mutation accelerates ApcMin/+ tumorigenesis. Mol. Cancer Res. 6: 1786–1793.
   PubMed Web of Science ®Google Scholar
• Yamamoto T, Nakahata Y, Soma H, Akashi M, Mamine T, Takumi T. (2004). Transcriptional oscillation of canonical clock genes in mouse peripheral tissues. BMC Mol. Biol. 5: 18.
   PubMed Web of Science ®Google Scholar
• Yang X, Wood PA, Oh EY, Du-Quiton J, Ansell CM, Hrushesky WJ. (2009). Down-regulation of circadian clock gene Period 2 accelerates breast cancer growth by altering its daily growth rhythm. Breast Cancer Res. Treat. 117: 423–431.
   PubMed Web of Science ®Google Scholar
• You S, Wood PA, Xiong Y, Kobayashi M, Du-Quiton J, Hrushesky WJ. (2005). Daily coordination of cancer growth and circadian clock gene expression. Breast Cancer Res. Treat. 91: 47–60.
   PubMed Web of Science ®Google Scholar